We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+4.96%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$562M
AUM Growth
+$227M
Cap. Flow
+$212M
Cap. Flow %
37.82%
Top 10 Hldgs %
51.62%
Holding
194
New
19
Increased
129
Reduced
11
Closed
24

Top Buys

Rank Stock Value
1
SHV icon
iShares 0-1 Year Treasury Bond ETF
SHV
+$22.2M
2
ETP
Energy Transfer Partners L.p.
ETP
+$22M
3
BPL
Buckeye Partners, L.P.
BPL
+$16.4M
4
ET icon
Energy Transfer Partners
ET
+$16.2M
5
WPZ
Williams Partners L.P.
WPZ
+$13.7M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$20.3M
2
IGM icon
iShares Expanded Tech Sector ETF
IGM
+$2.47M
3
IDU icon
iShares US Utilities ETF
IDU
+$2.2M
4
IYE icon
iShares US Energy ETF
IYE
+$2.06M
5
XLI icon
State Street Industrial Select Sector SPDR ETF
XLI
+$1.95M

Sector Composition

Rank Sector Weight
1 Energy 69.83%
2 Healthcare 9.07%
3 Utilities 2.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WELL.PRI
101
DELISTED
Welltower Inc.
WELL.PRI
$529K 0.09%
+8,378
New +$511K
CLVS
102
DELISTED
Clovis Oncology, Inc.
CLVS
$496K 0.09%
7,797
+743
+11% +$45.2K
IMMU
103
DELISTED
Immunomedics Inc
IMMU
$485K 0.09%
75,034
+7,193
+11% +$36.4K
LJPC
104
DELISTED
La Jolla Pharmaceutical Company
LJPC
$473K 0.08%
15,848
+1,519
+11% +$38.8K
SHLX
105
DELISTED
Shell Midstream Partners, L.P.
SHLX
$462K 0.08%
14,348
-40,955
-74% -$1.3M
KITE
106
DELISTED
Kite Pharma, Inc.
KITE
$461K 0.08%
5,877
+564
+11% +$34.9K
PNW icon
107
Pinnacle West Capital
PNW
$12.9B
$459K 0.08%
5,508
– –
XEL icon
108
Xcel Energy
XEL
$51B
$452K 0.08%
10,178
– –
LOXO
109
DELISTED
Loxo Oncology, Inc
LOXO
$438K 0.08%
10,408
+997
+11% +$41.1K
EPZM
110
DELISTED
Epizyme, Inc
EPZM
$434K 0.08%
25,328
+2,428
+11% +$32.3K
BCRX icon
111
BioCryst Pharmaceuticals
BCRX
$2.37B
$427K 0.08%
50,888
+4,878
+11% +$33.9K
BPMC
112
DELISTED
Blueprint Medicines
BPMC
$427K 0.08%
10,690
+1,025
+11% +$36.7K
AVXS
113
DELISTED
AveXis, Inc. Common Stock
AVXS
$425K 0.08%
5,585
+536
+11% +$33.2K
SAGE
114
DELISTED
Sage Therapeutics
SAGE
$415K 0.07%
5,837
+560
+11% +$32.8K
KPTI icon
115
Karyopharm Therapeutics
KPTI
$168M
$390K 0.07%
2,024
+194
+11% +$31.1K
FHLC icon
116
Fidelity MSCI Health Care Index ETF
FHLC
$3.27B
$389K 0.07%
+10,900
New +$381K
PRTK
117
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$389K 0.07%
20,209
+1,938
+11% +$30.5K
INSM icon
118
Insmed
INSM
$23.2B
$383K 0.07%
21,882
+2,097
+11% +$32.3K
RIGL icon
119
Rigel Pharmaceuticals
RIGL
$680M
$372K 0.07%
11,240
+1,077
+11% +$27.4K
BLUE
120
DELISTED
bluebird bio
BLUE
$369K 0.07%
313
+30
+11% +$30.6K
VNQ icon
121
Vanguard Real Estate ETF
VNQ
$39.9B
$365K 0.07%
4,415
+42
+1% +$3.48K
ONC
122
BeOne Medicines Ltd
ONC
$33.8B
$354K 0.06%
9,669
+927
+11% +$33.8K
MCRB icon
123
Seres Therapeutics
MCRB
$48.1M
$351K 0.06%
1,557
+150
+11% +$30.4K
JUNO
124
DELISTED
Juno Therapeutics, Inc.
JUNO
$347K 0.06%
15,654
+1,501
+11% +$32.2K
FOLD
125
DELISTED
Amicus Therapeutics
FOLD
$341K 0.06%
47,843
+4,587
+11% +$29K
3 4
5
6 7

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q1 2017 Portfolio in Review

As of Q1 2017, Virtus ETF Advisers held 194 positions worth $562M, up 68% from $335M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Virtus ETF Advisers deployed $212M of net new capital in Q1 2017, opening 19 new positions and adding to 129 existing holdings. Its largest new stake was Kinder Morgan: 272,117 shares worth $5.92M.

By sector, the portfolio is most concentrated in Energy at 70% of assets, up from 57% a quarter earlier, followed by Healthcare and Utilities.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $20.3M trimmed.

  • Virtus ETF Advisers's largest Q1 2017 buy was Kinder Morgan: 272,117 shares worth $5.92M.
  • Virtus ETF Advisers added most to iShares 0-1 Year Treasury Bond ETF in Q1 2017, an estimated $22.2M increase.
  • Virtus ETF Advisers's biggest Q1 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $20.3M.
  • Virtus ETF Advisers fully exited iShares Expanded Tech Sector ETF in Q1 2017, selling an estimated $2.47M.
  • Virtus ETF Advisers's ten largest holdings make up 52% of its $562M portfolio in Q1 2017.
  • Virtus ETF Advisers opened 19 new positions and closed 24 in Q1 2017.
  • Virtus ETF Advisers's portfolio value rose 68% quarter-over-quarter to $562M.

Based on Virtus ETF Advisers's 13F filing for Q1 2017, filed 15 May 2017.